Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotechnology Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Market Outlook Tesla Inc SAP AG
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Novo Nordisk A/S Markets BYD Co Ltd
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Biotech and Pharmaceuticals Social issues Healthy Returns
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags Europe Markets Breaking News: Markets Novo Nordisk A/S
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Pharmaceuticals US: News Health & Science
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Biotechnology Biotech and Pharmaceuticals Business
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Hims & Hers Health Inc Health & Science Health care industry
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Science Dexcom Inc Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Investment strategy 5 Things to Know Investing
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Markets Europe Markets Biotech and Pharmaceuticals
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Pharmaceuticals US: News Amgen Inc
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Pharmaceuticals US: News Health & Science
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Health & Science Microsoft Corp Health care industry
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Companies Health & Science Health care industry
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Business News Business Biotechnology
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Anheuser/Busch Inbev SA S&P 500 Business News
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Hims & Hers Health Inc Novo Nordisk A/S Science
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Bosch Ltd Europe News Ford Motor Co
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Novo Nordisk A/S Merck & Co Inc Breaking News: Business
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Health & Science Breaking News: Technology Internet
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Health care industry Companies Health & Science
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Earnings
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Biotech and Pharmaceuticals LILLY DRN Pharmaceuticals
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags LILLY DRN Healthy Returns Social issues
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Pfizer Inc Spotify Technology SA PayPal Holdings Inc
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Business News Science Novo Nordisk A/S
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Luxury Europe Economy Compagnie Financiere Richemont SA
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Social issues Venture capital CVS Health Corp
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.